The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
Voting is now open for the 2024 Company of the Year Awards
| 3 min read
What happened in May in the biopharma industry? Here’s our roundup of the biggest headlines.
| 6 min read
COVID-19 has taught us that unexpected events can cause significant supply chain disruption, so pharma must be prepared.
| 17 min read
How can pharma help save the environment? We need to use green chemistry, reduce cleanroom sizes, and use less energy.
Celebrate the people, companies, and innovations had the biggest impact on pharma in the last year.
by Thermo Fisher Scientific
Matthew Zustiak from Thermo Fisher Scientific discusses the challenges of equipment choice for producing mAbs.
Efficient and reliable scale up is a key component of mAb production.
Efficient, reliable scale up is a key component of mAb production. Thermo Fisher Scientific’s modularized system provides individual building blocks.
The Medicine Maker is proud to present the Power List 2022 and the inaugural Company of the Year Awards
Cytiva is transforming in the wake of COVID-19 – but what lessons can the wider biopharma industry take forward?
What happened in April in the biopharma industry? Here’s our roundup of the biggest headlines and research.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
What’s Happening with CAR T Therapies?
Pharma’s Portal to the Lab of the Future
The Sulforaphane Promise